Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease
Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials. © 2013 by The Society of Thoracic Surgeons.
Harskamp, RE; Zheng, Z; Alexander, JH; Williams, JB; Xian, Y; Halkos, ME; Brennan, JM; De Winter, RJ; Smith, PK; Lopes, RD
Volume / Issue
Start / End Page
Electronic International Standard Serial Number (EISSN)
International Standard Serial Number (ISSN)
Digital Object Identifier (DOI)